Does CEMIPLIMAB Cause Neoplasm progression? 9 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 9 reports of Neoplasm progression have been filed in association with CEMIPLIMAB (LIBTAYO). This represents 0.9% of all adverse event reports for CEMIPLIMAB.
9
Reports of Neoplasm progression with CEMIPLIMAB
0.9%
of all CEMIPLIMAB reports
5
Deaths
5
Hospitalizations
How Dangerous Is Neoplasm progression From CEMIPLIMAB?
Of the 9 reports, 5 (55.6%) resulted in death, 5 (55.6%) required hospitalization.
Is Neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CEMIPLIMAB. However, 9 reports have been filed with the FAERS database.
What Other Side Effects Does CEMIPLIMAB Cause?
Fatigue (68)
Pyrexia (49)
Pneumonia (41)
Dyspnoea (40)
Pneumonitis (38)
Off label use (35)
Diarrhoea (34)
Rash (34)
Cytokine release syndrome (33)
Pain (33)
What Other Drugs Cause Neoplasm progression?
PALBOCICLIB (10,885)
SUNITINIB MALATE (1,920)
CYCLOPHOSPHAMIDE (1,588)
CARBOPLATIN (1,370)
AXITINIB (1,315)
DOXORUBICIN (1,276)
LETROZOLE (1,225)
PACLITAXEL (1,180)
CRIZOTINIB (1,161)
VINCRISTINE (1,106)
Which CEMIPLIMAB Alternatives Have Lower Neoplasm progression Risk?
CEMIPLIMAB vs CEMIPLIMAB-RWLC
CEMIPLIMAB vs CENEGERMIN-BKBJ
CEMIPLIMAB vs CENOBAMATE
CEMIPLIMAB vs CEPHALEXIN
CEMIPLIMAB vs CERITINIB